Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2013

01.07.2013 | Article

Indicators show differences in antibiotic use between general practitioners and paediatricians

verfasst von: C. Pulcini, C. Lions, B. Ventelou, P. Verger

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this investigation was to adapt to an individual physician level and to the paediatric context a set of drug-specific indicators of outpatient antibiotic use developed by the European Surveillance of Antimicrobial Consumption (ESAC) project, and to describe the differences in antibiotic prescriptions between general practitioners (GPs) and paediatricians. We conducted a retrospective cross-sectional study analysing antibiotic prescriptions in 2009 for children below 16 years of age in south-eastern France, using the National Health Insurance (NHI) outpatient reimbursement database. A generalised linear model adjusted on physicians’ characteristics and patient population characteristics was used to compare indicators between GPs and paediatricians. We included 4,921 self-employed GPs and 301 paediatricians. Penicillins accounted for 47 % and 45 % of all antibiotics prescribed by GPs and paediatricians, respectively, followed by cephalosporins (33 % and 39 %) and macrolides (14 % and 9 %). In both specialties, there were around 70 % more antibiotic prescriptions during the winter quarters compared to the summer quarters. The 13 indicators we calculated showed wide variations in antibiotic prescriptions among GPs, among paediatricians, and between GPs and paediatricians. In an adjusted econometric model, GPs were found to issue 54 % more antibiotic prescriptions than paediatricians, whereas paediatricians used a significantly higher proportion of co-amoxiclav (18 % vs. 12 %) and cephalosporins (39 % vs. 33 %) and a significantly lower proportion of macrolides (9 % vs. 14 %) compared to GPs. A set of 13 indicators may be calculated using reimbursement data to describe outpatient antibiotic use at the physician level. We observed very different prescribing profiles between GPs and paediatricians.
Literatur
2.
Zurück zum Zitat Katz M, Rubino A, Collier J, Rosen J, Ehrich JH (2002) Demography of pediatric primary care in Europe: delivery of care and training. Pediatrics 109(5):788–796PubMedCrossRef Katz M, Rubino A, Collier J, Rosen J, Ehrich JH (2002) Demography of pediatric primary care in Europe: delivery of care and training. Pediatrics 109(5):788–796PubMedCrossRef
3.
Zurück zum Zitat Piovani D, Clavenna A, Cartabia M, Bonati M; Antibiotic Collaborative Group (2012) The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol 68(6):997–1005. doi:10.1007/s00228-011-1204-3 PubMedCrossRef Piovani D, Clavenna A, Cartabia M, Bonati M; Antibiotic Collaborative Group (2012) The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol 68(6):997–1005. doi:10.​1007/​s00228-011-1204-3 PubMedCrossRef
4.
Zurück zum Zitat Abbas S, Ihle P, Heymans L, Küpper-Nybelen J, Schubert I (2010) Differences in antibiotic prescribing between general practitioners and pediatricians in Hesse, Germany. Dtsch Med Wochenschr 135(37):1792–1797. doi:10.1055/s-0030-1263321 PubMedCrossRef Abbas S, Ihle P, Heymans L, Küpper-Nybelen J, Schubert I (2010) Differences in antibiotic prescribing between general practitioners and pediatricians in Hesse, Germany. Dtsch Med Wochenschr 135(37):1792–1797. doi:10.​1055/​s-0030-1263321 PubMedCrossRef
5.
Zurück zum Zitat Bocquet A, Chalumeau M, Bollotte D, Escano G, Langue J, Virey B (2005) Comparison of prescriptions by pediatricians and general practitioners: a population-based study in Franche-Comté from the database of Regional Health Insurance Fund. Arch Pediatr 12(12):1688–1696. doi:10.1016/j.arcped.2005.06.014 PubMedCrossRef Bocquet A, Chalumeau M, Bollotte D, Escano G, Langue J, Virey B (2005) Comparison of prescriptions by pediatricians and general practitioners: a population-based study in Franche-Comté from the database of Regional Health Insurance Fund. Arch Pediatr 12(12):1688–1696. doi:10.​1016/​j.​arcped.​2005.​06.​014 PubMedCrossRef
7.
Zurück zum Zitat Kozyrskyj AL, Dahl ME, Chateau DG, Mazowita GB, Klassen TP, Law BJ (2004) Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics. CMAJ 171(2):139–145. doi:10.1503/cmaj.1031629 PubMed Kozyrskyj AL, Dahl ME, Chateau DG, Mazowita GB, Klassen TP, Law BJ (2004) Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics. CMAJ 171(2):139–145. doi:10.​1503/​cmaj.​1031629 PubMed
8.
Zurück zum Zitat Adriaenssens N, Coenen S, Tonkin-Crine S, Verheij TJ, Little P, Goossens H; on behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf. doi:10.1136/bmjqs.2010.049049 Adriaenssens N, Coenen S, Tonkin-Crine S, Verheij TJ, Little P, Goossens H; on behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf. doi:10.​1136/​bmjqs.​2010.​049049
10.
Zurück zum Zitat Pulcini C, Lions C, Ventelou B, Verger P (2012) Approaching the quality of antibiotic prescriptions in primary care using reimbursement data. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-012-1743-2 Pulcini C, Lions C, Ventelou B, Verger P (2012) Approaching the quality of antibiotic prescriptions in primary care using reimbursement data. Eur J Clin Microbiol Infect Dis. doi:10.​1007/​s10096-012-1743-2
11.
Zurück zum Zitat Pulcini C, Lions C, Ventelou B, Verger P (2012) Drug-specific quality indicators assessing outpatient antibiotic use among French general practitioners. Eur J Public Health. doi:10.1093/eurpub/cks100 Pulcini C, Lions C, Ventelou B, Verger P (2012) Drug-specific quality indicators assessing outpatient antibiotic use among French general practitioners. Eur J Public Health. doi:10.​1093/​eurpub/​cks100
12.
Zurück zum Zitat Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, Monnet DL, Little P, Goossens H; ESAC Project Group (2007) European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 16(6):440–445. doi:10.1136/qshc.2006.021121 PubMedCrossRef Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, Monnet DL, Little P, Goossens H; ESAC Project Group (2007) European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 16(6):440–445. doi:10.​1136/​qshc.​2006.​021121 PubMedCrossRef
13.
Zurück zum Zitat Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother 66(Suppl 6):vi3–vi12. doi:10.1093/jac/dkr453 PubMedCrossRef Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H; ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother 66(Suppl 6):vi3–vi12. doi:10.​1093/​jac/​dkr453 PubMedCrossRef
14.
Zurück zum Zitat Davy T, Dick PT, Munk P (1998) Self-reported prescribing of antibiotics for children with undifferentiated acute respiratory tract infections with cough. Pediatr Infect Dis J 17(6):457–462PubMedCrossRef Davy T, Dick PT, Munk P (1998) Self-reported prescribing of antibiotics for children with undifferentiated acute respiratory tract infections with cough. Pediatr Infect Dis J 17(6):457–462PubMedCrossRef
15.
Zurück zum Zitat Mainous AG 3rd, Hueston WJ, Love MM (1998) Antibiotics for colds in children: who are the high prescribers? Arch Pediatr Adolesc Med 152(4):349–352PubMed Mainous AG 3rd, Hueston WJ, Love MM (1998) Antibiotics for colds in children: who are the high prescribers? Arch Pediatr Adolesc Med 152(4):349–352PubMed
16.
Zurück zum Zitat Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med 6(6):e1000084. doi:10.1371/journal.pmed.1000084 PubMedCrossRef Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med 6(6):e1000084. doi:10.​1371/​journal.​pmed.​1000084 PubMedCrossRef
17.
Zurück zum Zitat Pradier C, Rotily M, Cavailler P, Haas H, Pesce A, Dellamonica P, Obadia Y (1999) Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis 18(7):510–514PubMedCrossRef Pradier C, Rotily M, Cavailler P, Haas H, Pesce A, Dellamonica P, Obadia Y (1999) Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis 18(7):510–514PubMedCrossRef
18.
Zurück zum Zitat Schwartz RH, Freij BJ, Ziai M, Sheridan MJ (1997) Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners. Pediatr Infect Dis J 16(2):185–190PubMedCrossRef Schwartz RH, Freij BJ, Ziai M, Sheridan MJ (1997) Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners. Pediatr Infect Dis J 16(2):185–190PubMedCrossRef
19.
Zurück zum Zitat Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B (1999) Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics 104(6):1251–1257PubMedCrossRef Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B (1999) Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics 104(6):1251–1257PubMedCrossRef
20.
Zurück zum Zitat Arguedas A, Emparanza P, Schwartz RH, Soley C, Guevara S, de Caprariis PJ, Espinoza G (2005) A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 24(2):153–161PubMedCrossRef Arguedas A, Emparanza P, Schwartz RH, Soley C, Guevara S, de Caprariis PJ, Espinoza G (2005) A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 24(2):153–161PubMedCrossRef
21.
Zurück zum Zitat McCarty JM, Phillips A, Wiisanen R (1993) Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children. Pediatr Infect Dis J 12(12 Suppl 3):S122–S127PubMed McCarty JM, Phillips A, Wiisanen R (1993) Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children. Pediatr Infect Dis J 12(12 Suppl 3):S122–S127PubMed
22.
Zurück zum Zitat McLinn SE, Moskal M, Goldfarb J, Bodor F, Aronovitz G, Schwartz R, Self P, Ossi MJ (1994) Comparison of cefuroxime axetil and amoxicillin–clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother 38(2):315–318PubMedCrossRef McLinn SE, Moskal M, Goldfarb J, Bodor F, Aronovitz G, Schwartz R, Self P, Ossi MJ (1994) Comparison of cefuroxime axetil and amoxicillin–clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother 38(2):315–318PubMedCrossRef
23.
Zurück zum Zitat Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 58(2):423–427. doi:10.1093/jac/dkl183 PubMedCrossRef Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 58(2):423–427. doi:10.​1093/​jac/​dkl183 PubMedCrossRef
Metadaten
Titel
Indicators show differences in antibiotic use between general practitioners and paediatricians
verfasst von
C. Pulcini
C. Lions
B. Ventelou
P. Verger
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1828-6

Weitere Artikel der Ausgabe 7/2013

European Journal of Clinical Microbiology & Infectious Diseases 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.